The HYPMED project is developing a hybrid system of two medical imaging modalities (MRI and PET) for improved diagnosis of breast cancer and personalised therapy control. Breast cancer is the most common type of female cancer and continues to be one of the main causes of cancer death in women. Despite the advances made in modern medicine and contemporary targeted therapies, the stage of breast cancer at the time of diagnosis is still the most important driver of patient survival. This means that there is an obvious and persisting need for an improved early diagnosis of this disease.
The project`s aim is to develop a radiofrequency coil that can be connected to any regular clinical MR scanner and transform the device into a high-resolution PET/MRI hybrid system, which can be used to identify even the smallest breast cancer foci and better characterize the cancer as well as its response to therapy. Patients will also benefit as the radiation dose of the new technology will, in contrast to other PET-MRI examinations, be comparable to a regular digital mammogram.
The HYPMED project is a four-year project aimed at developing a hybrid system of two medical imaging modalities (MRI and PET) for improved diagnosis of breast cancer and personalised therapy control.
The HYPMED project consists of six interdependent work packages, each of which contains tasks and deliverables vital to the project's success.
Keep track of the latest results from the HYPMED project by reading our public deliverables
The HYPMED consortium is made up of ten partner organiastions from Europe. The consortium includes major universities, research institutes, clinics as well as major industry and small-to-medium-sized enterprises.
With the success of the HYPMED project, we will open up a whole new chapter of medical hybrid imaging
If you have any questions about the HYPMED Project, please feel free to contact us by using the message form below
Prof. Christiane Kuhl is head of the Department of Diagnostic and Interventional Radiology at the RWTH University Hospital Aachen.
Monika Hierath is executive manager at EIBIR with more than a decade of experience in managing European level research projects.
HYPMED
This project has received funding from the European Union‘s Horizon 2020 research and innovation programme under grant agreement No 667211
